Caption Management’s Acceleron Pharma XLRN Stock Holding History

Caption Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,600	Closed	-$5.61M	–	2099
2021 Q3	$5.61M	Buy	32,600 +12,600	+63%	+$1.65M	0.06%	409
2021 Q2	$2.51M	Buy	+20,000	New	+$2.52M	0.03%	599
2020 Q3	–	Sell	-50,000	Closed	-$4.76M	–	1365
2020 Q2	$4.76M	Buy	50,000 +1,500	+3%	+$145K	0.16%	173
2020 Q1	$4.36M	Buy	48,500 +18,500	+62%	+$1.44M	0.25%	117
2019 Q4	$1.59M	Buy	+30,000	New	+$1.37M	0.05%	397
2018 Q3	–	Sell	-10,000	Closed	-$485K	–	686
2018 Q2	$485K	Buy	+10,000	New	+$364K	0.04%	322

Caption Management's XLRN Position: Q4 2021 in Review

Caption Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,760 shares — an estimated $1.16M sold.

Caption Management first reported a position in XLRN in Q2 2018 and held it in 4 quarters. The position peaked at $2.94M in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Caption Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Caption Management sold 6,760 Acceleron Pharma shares in Q4 2021, an estimated $1.16M.
Caption Management first reported a position in Acceleron Pharma in Q2 2018 and held it in 4 quarters.
Caption Management's Acceleron Pharma position peaked at $2.94M in Q2 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.